Related Experiment Videos
Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells
1Department of Pathology, The University of Hong Kong, Queen Mary Hospital, China.
Abstract:
The p16INK4a tumor suppressor gene is frequently inactivated in nasopharyngeal carcinoma (NPC) and hence it may play an important role in the suppression of this tumor. In order to study the effect of p16INK4a restoration in NPC cells, full-length human p16INK4a gene was transfected into a NPC cell line, CNE1. Four individual clones with differential levels of p16INK4a protein expression, were selected for further studies. The introduction of p16INK4a into CNE1 cells induced growth suppression through G0/G1 cell cycle arrest; however, the cell growth rate was not correlated to the levels of p16INK4a protein expression. To study whether transfection of p16INK4a could protect NPC cells from radiation, cisplatin and 5-fluorouracil (5FU), the cellular sensitivity of p16INK4a transfectants and vector control were investigated. An increase in sensitivity to 5FU was observed (2-fold compared to IC50) in all 4 clones compared to vector-transfected control. P16INK4a transfection also resulted in increased sensitivity to cisplatin (1.5-1.8-fold) in 3 out of 4 cell lines. However, no difference in radiosensitivity was found between the p16INK4a transfectants and the control. These findings indicate that p16INK4a suppresses NPC cell growth through G0/G1 arrest and modulating cellular response to chemotherapeutic drugs in NPC cells. Therefore, restoration of p16INK4a may have a therapeutic purpose in the treatment of NPC.
Insights
Restoring the p16INK4a tumor suppressor gene in nasopharyngeal carcinoma (NPC) cells suppressed growth and increased sensitivity to chemotherapy drugs like 5FU and cisplatin. This suggests p16INK4a holds therapeutic potential for NPC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Nasopharyngeal carcinoma (NPC) frequently shows inactivation of the p16INK4a tumor suppressor gene.
- p16INK4a plays a crucial role in tumor suppression, making its restoration a potential therapeutic strategy for NPC.
Purpose of the Study:
- To investigate the functional effects of restoring p16INK4a expression in NPC cells.
- To determine if p16INK4a influences NPC cell growth, cell cycle progression, and sensitivity to chemotherapy and radiation.
Main Methods:
- Full-length human p16INK4a gene was transfected into the CNE1 NPC cell line.
- Four clones with varying p16INK4a expression levels were selected for analysis.
- Cellular sensitivity to 5-fluorouracil (5FU), cisplatin, and radiation was assessed.
Main Results:
- p16INK4a introduction induced growth suppression via G0/G1 cell cycle arrest in NPC cells.
- All p16INK4a-expressing clones showed a 2-fold increase in sensitivity to 5FU.
- Three out of four clones exhibited 1.5-1.8-fold increased sensitivity to cisplatin, but radiosensitivity remained unchanged.
Conclusions:
- Restoration of p16INK4a effectively suppresses NPC cell growth by inducing G0/G1 arrest.
- p16INK4a modulates NPC cell responses to chemotherapeutic agents, enhancing sensitivity to 5FU and cisplatin.
- Restoring p16INK4a represents a promising therapeutic approach for treating nasopharyngeal carcinoma.